Applied DNA Sciences (NASDAQ:APDN ) | WebDisclosure

Switch to English

10238	Sociétés
211363	Mots-clés
141296	Articles
111973	Communiqués

Accueil
Sociétés
Applied DNA Sciences

COMMUNIQUÉ DE PRESSE

publié le 15/10/2024 à 16:30, il y a 1 année 6 mois

Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16
Applied DNA Sciences to participate in Maxim Healthcare Virtual Summit with CEO Dr. James A. Hayward in a fireside chat on October 16, 2024. Company overview and business focus detailed

Biotechnology Company Applied DNA Sciences PCR-based DNA Technologies Maxim Healthcare Virtual Summit CEO Interview
BRÈVE

publiée le 18/09/2024 à 15:05, il y a 1 année 7 mois

Applied DNA retrouve sa conformité avec l'exigence de prix d'offre minimum du Nasdaq

Bourse Conformité Au Nasdaq ADN Appliqué Prix De L'offre Technologies Basées Sur La PCR
BRÈVE

publiée le 18/09/2024 à 15:05, il y a 1 année 7 mois

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement

Nasdaq Compliance Stock Market Bid Price Applied DNA PCR-based Technologies
COMMUNIQUÉ DE PRESSE

publié le 18/09/2024 à 15:00, il y a 1 année 7 mois

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
Applied DNA Sciences, Inc. regains compliance with Nasdaq minimum bid price requirement. Full details on the company's PCR-based DNA technologies and markets

Biotechnology Forward-looking Statements Nasdaq Compliance Applied DNA Sciences PCR-based DNA
BRÈVE

publiée le 17/09/2024 à 15:20, il y a 1 année 7 mois

Applied DNA Presents Linea IVT Platform at mRNA Summit

Applied DNA Sciences Linea IVT Platform MRNA Summit Kudo Biotechnology DsRNA Mitigation
BRÈVE

publiée le 17/09/2024 à 15:20, il y a 1 année 7 mois

Applied DNA présente la plateforme Linea IVT au mRNA Summit

Sciences Appliquées De L'ADN Plateforme Linea IVT Sommet Sur L'ARNm Biotechnologie Kudo Atténuation Des ARNdb
COMMUNIQUÉ DE PRESSE

publié le 17/09/2024 à 15:15, il y a 1 année 7 mois

Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 3rd Annual mRNA Process Development & Manufacturing Summit
Applied DNA Sciences to showcase Linea IVT platform for rapid mRNA manufacturing at mRNA events in Boston. Co-hosts seminar with Kudo Bio to demonstrate capabilities

Applied DNA Sciences Linea IVT Platform MRNA Manufacturing Kudo Bio MRNA Events
BRÈVE

publiée le 17/09/2024 à 15:05, il y a 1 année 7 mois

Applied DNA obtient une importante commande complémentaire d'un fabricant de dispositifs de diagnostic in vitro

Technologie PCR ADN Appliqué Diagnostic Du Cancer DIV Ligne ADN
BRÈVE

publiée le 17/09/2024 à 15:05, il y a 1 année 7 mois

Applied DNA Secures Significant Follow-on Order from IVD Manufacturer

Cancer Diagnostics Linea DNA PCR Technology Applied DNA IVD
COMMUNIQUÉ DE PRESSE

publié le 17/09/2024 à 15:00, il y a 1 année 7 mois

Applied DNA Receives Linea DNA Follow-on Order from Global Manufacturer of IVDs for Cancer Diagnostic Application
Applied DNA Sciences receives a follow-on order for Linea DNA from a global IVD manufacturer valued at over $500,000, reflecting customer commitment and recurring orders. Dr. James A. Hayward optimistic about meeting growing industry needs

Applied DNA Sciences Linea DNA IVD Manufacturer Recurring Order Diagnostic Industry

Les Echos

Publié le 17/04/2026 à 20:30, il y a 1 jour 13 heures

ALTAREA - Déclaration d’opérations sur actions propres
Publié le 17/04/2026 à 19:00, il y a 1 jour 14 heures

Cegedim : Publication du Document d’Enregistrement Universel 2025
Publié le 17/04/2026 à 19:00, il y a 1 jour 14 heures

Cegedim: Release of its 2025 Universal Registration Document
Publié le 17/04/2026 à 17:45, il y a 1 jour 16 heures

Carrefour announces the sale of its minority stake in CarrefourSA in Turkey to Aydın
Publié le 17/04/2026 à 17:45, il y a 1 jour 16 heures

Carrefour annonce la cession de sa participation minoritaire dans CarrefourSA en Turquie à Aydın

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 18/04/2026 à 04:00, il y a 1 jour 5 heures

Formation Metals Responds to OTC Markets Request on Recent Promotional Activity
Publié le 18/04/2026 à 02:00, il y a 1 jour 7 heures

AI/ML Innovations Announces Completion of Share Issuance
Publié le 18/04/2026 à 01:35, il y a 1 jour 8 heures

Medicure Announces Resignation of President and Chief Operating Officer
Publié le 18/04/2026 à 01:00, il y a 1 jour 8 heures

Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development
Publié le 18/04/2026 à 00:00, il y a 1 jour 9 heures

Redwood AI Announces Collaboration with Aidos Innovations, Aimed at Enhancing Public Safety Collaboration with B.C. Government, Canadian Federal and Local Law Enforcement Agencies to Tackle the Fentanyl Crisis in British Columbia

Voir tout ACCESSWIRE

EQS Group

Publié le 18/04/2026 à 00:05, il y a 1 jour 9 heures

ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds
Publié le 17/04/2026 à 21:39, il y a 1 jour 12 heures

Linedata Services: Mise à disposition du Document d’Enregistrement Universel 2025 incluant le Rapport Financier Annuel 2025
Publié le 17/04/2026 à 20:33, il y a 1 jour 13 heures

LLB General Meeting 2026 – Shareholders approve all proposals of the Board of Directors
Publié le 17/04/2026 à 19:35, il y a 1 jour 14 heures

Stabilisation Notice
Publié le 17/04/2026 à 19:30, il y a 1 jour 14 heures

KAP AG: REFINANCING CONCEPT AGREED; NEW SYNDICATED LOAN SECURES FLEXIBILITY FOR THE ONGOING TRANSFORMATION PROCESS